GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Effective Interest Rate on Debt %

Pharmosa Biopharm (ROCO:6875) Effective Interest Rate on Debt % : 1.92% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmosa Biopharm's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was NT$2.2 Mil. Pharmosa Biopharm's average total debt for the quarter that ended in Mar. 2025 was NT$115.4 Mil. Therefore, Pharmosa Biopharm's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 1.92%.


Pharmosa Biopharm Effective Interest Rate on Debt % Historical Data

The historical data trend for Pharmosa Biopharm's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Effective Interest Rate on Debt % Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 3.09 1.50 2.23 3.45 1.85

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.77 2.04 1.91 1.92

Competitive Comparison of Pharmosa Biopharm's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Pharmosa Biopharm's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmosa Biopharm's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's Effective Interest Rate on Debt % falls into.


;
;

Pharmosa Biopharm Effective Interest Rate on Debt % Calculation

Pharmosa Biopharm's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -2.419/( (144.369+117.599)/ 2 )
=-1  *  -2.419/130.984
=1.85 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=118.415 + 25.954
=144.369

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=99.616 + 17.983
=117.599

Pharmosa Biopharm's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -2.216/( (117.599+113.159)/ 2 )
=-1  *  -2.216/115.379
=1.92 %

where

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=99.616 + 17.983
=117.599

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=95.023 + 18.136
=113.159

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Pharmosa Biopharm  (ROCO:6875) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Pharmosa Biopharm Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmosa Biopharm Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 508, Sec. 7, Zhongxiao E. Road, 11F / 11F-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology. Geographically, the company generates almost all of its revenue from the USA, and a small portion from Taiwan.

Pharmosa Biopharm Headlines

No Headlines